BIOFIRE® FILMARRAY® Tropical Fever Panel, a syndromic PCR test targeting…
Read More »
Prolaris, MyRisk, and Precise Tumor Testing Validated Across Cancer Stages,…
Presentations include analytical validation of Myriad’s high-definition tumor informed MRD…
Presentation to Highlight Feasibility and Interest in Decentralized Home-Based Phase…
November 27, 2024—Fluidx Medical Technology, Inc. announced that the first…
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) —…
Canary Speech recognized for achievements in non-invasive diagnostics in the…
First program to result from end-to-end use of OS to…
Embolic device designed for improved preparation, delivery, and deep vessel…
EDWARDS’ SAPIEN 3 ULTRA RESILIA VALVE DEMONSTRATES CONTINUED EXCELLENT OUTCOMES…
WRAPSODY achieves 82% target lesion primary patency at six months…
More than a dozen Utah legislators on Wednesday, November 20,…
Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed…
Agreement will expand worldwide access and better position Myriad’s GIS…
Four Integration Methods Aim to Combat Healthcare-Associated Infections & Improve…
SINTX TECHNOLOGIES AND NED MEDICAL PARTNER TO ADVANCE CUTTING-EDGE CERAMIC…
First of Its Kind HPV Self-Collection Study Launched to Improve…
Seek Labs Announces Partnership with Cerbrec
Update call scheduled for November 20th at 7:30 a.m. Eastern…
OpenPhenom is a non-commercial, publicly available foundation model built on…
Notifications
